Early hominin species survived as late as 14,000 years ago in China: study

Early hominin species survived as late as 14,000 years ago in China: study

A species of early hominin might have survived as late as 14,000 years ago in southwest China, an analysis of an ancient fossilized femur or thigh bone suggested.

The bone, which was unearthed along with other human remains at a site called Maludong or Red Deer Cave in southwest China in 1989, resembles those of an ancient human species who were previously thought went extinct by the Late Pleistocene.

Full Moon to brighten night sky before Christmas Day 2015

Full Moon to brighten night sky before Christmas Day 2015

This year’s Christmas will be different from most others as a rare full Moon will brighten the night sky before the Sun rises on Christmas Day 2015.

As Santa and his reindeer will be busy in delivering gifts on Christmas Eve, the rare full Moon will be shining overnight. It is going to be the first full Moon on Christmas Day since the year of 1977.

According to astronomers with American space agency NASA, the Moon will reach its peak size, which is called perigee by scientists, at 5:11 a.m. central or 6:11 a.m. eastern time on Christmas Day.

Topics: 

NASA releases Star Wars-themed images of ‘cosmic lightsaber’

NASA releases Star Wars-themed images of ‘cosmic lightsaber’

The National Aeronautics & Space Administration (NASA) has released Star Wars-themed images of a huge ‘cosmic lightsaber’ that appears to be cutting through dark space.

The American space agency said it spotted the huge lightsaber in an area of space clouds where new stars are born. The images of a bright, space light resemble the weapons wielded in popular space film franchise Star Wars cutting through the darkness of space.

Topics: 

Aim of a new bill in France is to do away with use of ‘excessively thin’ models

Aim of a new bill in France is to do away with use of ‘excessively thin’ models

According to a bill, France has passed on Thursday aiming at making the use of super skinny fashion models banned in the fashion industry, the models will need to obtain a medical approval by doctor to work in the industry.

The French National Assembly’s passed law wants models to visit a doctor, and asks for photographs that have been edited to change the appearance of a model to carry a caption that indicates the alteration. BBC News reported that the aim of the law is to do away with the use of ‘excessively thin’ models.

Topics: 

Beijing Residents Stuck Indoors as Heavy Smog Covers China’s Capital

Beijing Residents Stuck Indoors as Heavy Smog Covers China’s Capital

Heavy smog has covered China’s capital Beijing and this has forced residents to stay indoors. Schools were also closed and people were asked to limit the use of cars for travelling.

Cars in the area with even-numbered license plates were banned, and schools and constructions sites and factories also remained closed on Wednesday, the second of the three-day restrictions triggered by the city's first red alert for smog.

Topics: 

Rise in Temperature of Lakes around World may Lead To Rapid Toxic Algae Outbreak

Rise in Temperature of Lakes around World may Lead To Rapid Toxic Algae Outbreak

New study has shown that lakes throughout the world are warming at a faster average rate than oceans and the atmosphere. Warming of lakes will trigger toxic algae bloom, warn researchers.

The study co-funded by NASA and the National Science Foundation suggested that increase in lake temperature is projected to increase alga blooms by almost 20%, and toxic algae bloom by 5%.

The warm lake water could also alter the balance of ecosystems and threaten the livelihood of people who depend on fish from the lakes.

Zolpidem Can Enhance Recovery from Stroke, say researchers

Zolpidem Can Enhance Recovery from Stroke, say researchers

A drug used to treat insomnia can actually enhance the recovery from stroke, researchers found during a recent study. The drug Zolpidem, is better known by the trade name Ambien.

Zolpidem is a new class of sleeping pills that are sold under the brands Stilnoct and Edluar in the UK and Ambien in the US. The drug is given to around 750,000 NHS patients each year.

FDA anticipates giving its decision on BioMarin Pharmaceutical Inc's lead drug in early January

FDA anticipates giving its decision on BioMarin Pharmaceutical Inc's lead drug in early January

The deadline to decide on drug developer BioMarin Pharmaceutical Inc's lead drug has been pushed back by the U.S. Food and Drug Administration. The FDA hasn’t rejected it right away, keeping a ray of hope among shareholders.

The company made the announcement regarding the delay from the FDA on Friday, saying that the federal agency isn’t done with the drug review so far. The drug has been designed for the treatment of rare disorder Duchenne muscular dystrophy (DMD).

Topics: 

Pages

Subscribe to NewsPoint Africa RSS